Olmis (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxomil, the active ingredient in Olmis, is an angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It treats hypertension and may be used in adults who require additional blood pressure control. GNH USA supplies Olmis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmis combines an ARB with a thiazide diuretic to lower blood pressure through complementary mechanisms.

- Hypertension: helps achieve target blood pressure when monotherapy is insufficient. - Heart failure: assists in reducing fluid overload and controlling blood pressure. - Diabetic nephropathy: slows progression by lowering systemic pressure. - Post‑myocardial infarction: contributes to secondary prevention of cardiovascular events. - Chronic kidney disease: aids in blood pressure control to protect renal function.

Adverse reactions can range from mild to severe and should be monitored during therapy.

Common Side Effects: - Dizziness - Headache - Fatigue - Increased urination - Electrolyte imbalance (low potassium) - Mild renal function changes

Serious or Rare Side Effects: - Severe hypotension - Acute kidney injury - Hyperkalemia - Angio‑edema - Severe electrolyte disturbances - Liver function abnormalities.

Olmis should be used with caution in specific clinical situations and according to professional guidance.

- Renal impairment: adjust dose and monitor function. - Hepatic impairment: use with caution, monitor liver enzymes. - Electrolyte disorders: check potassium and sodium levels regularly. - Pregnancy: contraindicated in the second and third trimesters. - Concomitant potassium‑sparing agents: risk of hyper‑kalaemia. - Store at ambient temperature: keep in the original packaging.

Olmis may interact with several medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Potassium‑rich foods/​    ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ​  ​ -  

Moderate